TSX open
Loading markets…

Advertisement

Stocks

IDEXX Laboratories to Release 2026 Third Quarter Financial Results

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:IDXX.US

Follow IDXX

Photos provided by Pexels

IDEXX Laboratories has announced its upcoming release of third quarter financial results for 2026.

IDEXX Laboratories Inc is set to share its financial results for the third quarter of 2026. The announcement follows a day when the company's stock closed at US$520.24, reflecting a 1.67% increase, but a decline of 21.33% year-to-date.

Investor takeaway: Investors will closely watch the earnings report for insights into IDEXX's ongoing performance and market strategy.

Advertisement

IDEXX Laboratories Inc

IDXX.US

Full stock page →

IDXX.US

IDEXX Laboratories Inc

Source:WealthAwesomeWealthAwesome
↓ $53.69 (-9.24%)
120 day period
$504.70$550.23$595.76Apr 15Jul 13Oct 5

Market cap

$40.89B

P/E

36.4x

52W high

$769.98

52W low

$500.61

1W change

-0.38%

Beta

1.54

Analyst Price Targets

Based on 13 analysts covering IDXX · as of Oct 5, 2026

📈

Wall Street analysts forecast IDXX stock price to rise 33.1% over the next 12 months.

Consensus

Buy

3.85 / 5.00

Avg. Target

C$701.33

+33.1% Upside

Current Price

C$527.07

Last close

Analyst Breakdown (13 analysts)

Strong Buy 4
Buy 4
Hold 4
Sell 1
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on IDXX's historical volatility

HistoricalForecast68%95%
C$357.64C$413.08C$468.52C$523.96C$579.40C$634.84TodayMay 28Aug 3Oct 5Nov 17Dec 31Feb 12

30-Day Vol

21.5%

Annualized

90-Day Vol

29.1%

Annualized

Trend (90d)

-28.1%

Annualized drift

90d Mean

C$476.70

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$509.72C$473.28 – C$548.96
60 trading daysC$492.93C$443.85 – C$547.45
90 trading daysC$476.70C$419.24 – C$542.05

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

IDEXX's Last Close at $520.24 with 60,109 Shares Traded

The latest trading volume was 1.23 times the 20-day average of 479,215 shares, indicating heightened interest ahead of the earnings release.

Bull case

If the earnings report is positive, it could lead to a rebound in the stock price, potentially moving closer to the average analyst target of US$701.33, suggesting a 34.8% upside from the current price.

Bear case

On the other hand, if the earnings report shows underperformance, it could further depress the stock, which has already declined by 1.55% over the past month.

IDEXX Plans Earnings Release

Advertisement

IDEXX Laboratories has announced its plan to release its third quarter financial results for 2026. This event is crucial for investors, as it will provide insights into the company's performance amidst a challenging market landscape. The last close was US$520.24, with the stock experiencing a 1.67% increase in the last trading session. However, it has been down 21.33% year-to-date, highlighting ongoing challenges.

Current Stock Performance and Trading Volume

As of the last trading session, IDEXX's stock closed at US$520.24, reflecting a 1.67% increase. The trading volume was 60,109 shares, which is 1.23 times the 20-day average of 479,215 shares, indicating increased investor interest ahead of the earnings release. The stock price is currently 4.3% below its 50-day moving average of US$543.80 and 11.5% below the 200-day moving average of US$587.95, suggesting further scrutiny may be warranted.

What to Watch for in the Earnings Report

Investors will be looking for specific metrics such as revenue growth, profit margins, and updates regarding IDEXX's strategic initiatives. The company has a P/E ratio of 36.40 and a profit margin of 25.0%. Given the current market conditions and IDEXX's year-to-date decline of 21.33%, the earnings report will be pivotal in shaping future investor sentiment. The stock remains within 7% of its 52-week range of US$500.61 to US$769.98, adding to the importance of the upcoming results.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 6, 2026
Last Updated: October 6, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement